Mark A. Dickson, MD

Pictured: Mark Dickson

Medical oncologist Mark Dickson talks about the specialized treatment that Memorial Sloan Kettering offers to people with melanoma, sarcoma, and Kaposi sarcoma.


I am a medical oncologist who specializes in the treatment of sarcomas of soft tissue and bone, Kaposi’s sarcoma, and melanoma. My research is focused on the development of new drugs, including targeted small molecules and antibodies, to treat these diseases.  In particular, I study new drugs that block pathways and proteins critical for cancer growth such as the cell cycle pathway in liposarcoma, the Aurora kinase proteins in soft tissue sarcoma, and the Notch pathway in melanoma.  My research includes work in HIV-associated Kaposi’s sarcoma in concert with the AIDS Malignancy consortium.  My goal is to find newer, more-effective, and less-toxic therapies to improve the lives of people living with cancer.

Appointments for New Patients
Clinical Expertise

Sarcomas of Soft Tissue and Bone; Kaposi’s Sarcoma; Melanoma

Languages Spoken

MD, Columbia University College of Physicians & Surgeons


New York-Presbyterian Hospital/Weill Cornell Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Hematology; Medical Oncology

Publications by Mark A. Dickson
Visit PubMed for full listing of Mark A. Dickson journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.